Journal Information

Statistics

Follow this link to access the full text of the article

Original article
Xanthine oxidoreductase inhibitor topiroxostat ameliorates podocyte injury by inhibiting the reduction of nephrin and podoplanin
El inhibidor de la xantina oxidorreductasa, topiroxostat, mejora la lesión de los podocitos al inhibir la reducción de nefrina y podoplanina
Ying Zhanga, Yoshiyasu Fukusumia, Mutsumi Kayabaa, Takashi Nakamurab, Ryusuke Sakamotob, Naoki Ashizawac, Hiroshi Kawachia,
Corresponding author
kawachi@med.niigata-u.ac.jp

Corresponding author.
a Department of Cell Biology, Kidney Research Center, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
b Pharmacological Study Group, Pharmaceutical Research Laboratories, Sanwa Kagaku Kenkyusho, Mie, Japan
c Biological Research Group, Research Department, Medical R&D Division, Fuji Yakuhin, Saitama, Japan
Read
2922
Times
was read the article
1324
Total PDF
1598
Total HTML
Share statistics
Article information
ISSN: 20132514
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 March 65 38 103
2024 February 48 85 133
2024 January 33 36 69
2023 December 30 43 73
2023 November 61 45 106
2023 October 120 64 184
2023 September 79 40 119
2023 August 52 37 89
2023 July 49 51 100
2023 June 40 31 71
2023 May 49 40 89
2023 April 37 41 78
2023 March 75 55 130
2023 February 63 28 91
2023 January 49 38 87
2022 December 68 39 107
2022 November 61 56 117
2022 October 73 88 161
2022 September 50 33 83
2022 August 45 43 88
2022 July 58 53 111
2022 June 52 49 101
2022 May 67 31 98
2022 April 87 59 146
2022 March 44 56 100
2022 February 52 52 104
2022 January 67 67 134
2021 December 24 26 50
Show all

Follow this link to access the full text of the article

Idiomas
Nefrología (English Edition)
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?